GSK Plc raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s ...
GSK lifted profit expectations for the year after the pharma group's sales were boosted by bumper demand for HIV and cancer ...
GSK raised its full-year guidance on Wednesday, after delivering stronger-than-expected third-quarter results, driven by ...
Cash generated from operations totaled £2.5 billion, with free cash flow of £1.2 billion. GSK declared a dividend of 16 pence ...
GSK has received approval from the US Food and Drug Administration (FDA) for Blenrep (belantamab mafodotin-blmf) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback